HomeXRTX • NASDAQ
add
XORTX Therapeutics Inc
Previous close
$0.65
Day range
$0.64 - $0.64
Year range
$0.52 - $1.79
Market cap
5.92M CAD
Avg Volume
131.74K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 479.35K | -21.07% |
Net income | -649.47K | -10.64% |
Net profit margin | — | — |
Earnings per share | -0.20 | — |
EBITDA | -471.99K | 18.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.19M | -48.11% |
Total assets | 2.81M | -26.99% |
Total liabilities | 837.41K | -51.22% |
Total equity | 1.97M | — |
Shares outstanding | 6.96M | — |
Price to book | 1.71 | — |
Return on assets | -43.16% | — |
Return on capital | -57.84% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -649.47K | -10.64% |
Cash from operations | -629.62K | 16.26% |
Cash from investing | -5.49K | 76.33% |
Cash from financing | 770.88K | 3,566.49% |
Net change in cash | 130.44K | 116.77% |
Free cash flow | -85.77K | 84.35% |
About
Founded
2011
Headquarters
Website
Employees
3
